HIV / AIDS in the News

Mount Sinai Researchers Develop Method to Identify Dormant Cells That Carry HIV | Newswise - Newswise

 

SP-38 potently inhibits HIV-1 replication by inducing defective particle morphology - BioWorld Online

 

The Global Health Challenge of HIV and Hepatitis B Coinfections - Gilead Sciences

 

Global health update: March 13, 2025 - George W. Bush Presidential Center

 

ViiV Healthcare’s N6LS shows promise in long-acting HIV treatment - World Pharmaceutical Frontiers

 

Devex CheckUp: USAID cuts threaten global health research - Devex

 

Impact of US funding freeze on HIV programmes in Haiti - UNAIDS

 

EnnoDC presents positive Phase I data at CROI 2025, - GlobeNewswire

 

If Twice-Yearly Lenacapavir Could Be a HIV PrEP Game Changer, Would a Once-Yearly Version Be a HIV Epidemic Ender? - Managed Healthcare Executive

 

Late-Breaking Antiviral Session Features Phase 3 Results on Efficacy of Doravirine/Islatravir - AJMC.com Managed Markets Network

 

ViiV to trial twice-yearly HIV antibody dosing after Phase IIb success - Clinical Trials Arena

 

MSD to push for approval of HIV combo after Phase III success - Clinical Trials Arena

 

The role of digital tools in enhancing antiretroviral therapy adherence among adolescents and young adults with HIV: a systematic review of randomized controlled trials - BMC Infectious Diseases

 

Antiretrovirals Alone Don’t Delay Language in Children - Medscape

 

ViiV Healthcare’s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV - News-Medical.Net

 

Cuts to USAID-funded research another blow to global HIV response - Devex

 

Impact of US funding freeze on HIV programmes in Kenya - UNAIDS

 

Scientists develop yearly HIV injection: How it could help millions - The Times of India

 

HIV self-testing is easy, effective — and underutilized - STAT

 

Couples Counseling Key to HIV Prevention and Maternal Care - AJMC.com Managed Markets Network

 

Mount Sinai Researchers Develop Method to Identify Dormant Cells That Carry HIV - Mount Sinai

 

Curing HIV—How Far Have We Come? - amfAR, The Foundation for AIDS Research

 

ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved for HIV PrEP - BioSpace

 

BPHC Launches Campaign to Raise Awareness of HIV Treatment Resources - Beacon Hill Times

 

Bridging Gaps in HIV Care Through Pharmacy-Based Solutions - AJMC.com Managed Markets Network

 

IL proposal could remove insurance companies from blocking HIV medication - WAND

 

Frailty, Housing Instability Drive Mortality Risk in People With HIV - AJMC.com Managed Markets Network

 

ViiV to pursue six-month dosing for HIV antibody after positive Phase II readout - FirstWord Pharma

 

Long-Acting Injectable Cabotegravir Effective in Both ART, PrEP - AJMC.com Managed Markets Network

 

GSK, Pfizer's ViiV Healthcare Shows Strong HIV Viral Suppression In Latest Study - Benzinga